Multistakeholder workshop on EMA’s extended mandate
Table of contents
Date:
01/04/2022
Location:
Online
The European Medicines Agency (EMA) is holding this workshop to inform stakeholders of the regulation reinforcing EMA’s role in crisis preparedness and management for medicines and medical devices.
It covers the following topics:
- Monitoring and mitigating shortages of medicines and devices
- Addressing public health emergencies through the Emergency Task Force (ETF)
- Coordinating expert panels on high-risk medical devices and in vitro diagnostics
The event also provides an opportunity for the public and stakeholders to inform EMA of their needs, expectations and discuss opportunities for further engagement.
Full video recording
Introduction
Session 1: Monitoring and mitigating shortages of medicines and devices
Session 2: Addressing public health emergencies through the Emergency Task Force (ETF)
Session 3: Coordinating expert panels on high-risk medical devices and in vitro diagnostics
-
List item
Agenda - Multistakeholder workshop on EMA’s extended mandate (PDF/633.74 KB)
Draft
First published: 07/03/2022
Last updated: 05/04/2022 -
List item
Report - Multistakeholder workshop on EMA’s extended mandate (PDF/461.88 KB)
First published: 18/11/2022 -
List item
Presentation - Opening statements from stakeholders (A. van der Hoven) (PDF/522.57 KB)
First published: 05/04/2022 -
List item
Presentation - Session 1: Monitoring and mitigating shortages of medicines and devices (J. Ferreira, EMA) (PDF/473.29 KB)
First published: 05/04/2022 -
List item
Presentation - Session 2: Addressing public health emergencies through the ETF (M. Mura, EMA) (PDF/322.03 KB)
First published: 05/04/2022 -
List item
Presentation - Session 3: Coordinating expert panels on high-risk medical devices and in vitro diagnostics (S. da Rocha Dias, EMA) (PDF/727.18 KB)
First published: 05/04/2022 -
List item
Presentation - The European Health Union (PDF/116.83 KB)
First published: 05/04/2022